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Interaction between Smoking and Asbestos in
Human Lung Adenocarcinoma: Role of K-ras
Mutations
by Harri Vainio,1 Kirsti Husgafvel-Pursiainen,3 Sisko
Anttila,3 Antti Karjalainen, Peter Hackman, and Timo
Partanen3
To investigate the role of tobacco smoking and asbestos fibers in the etiology of human lung cancer, we
examined the activating point mutations in the K-ras oncogene in DNA samples from 49 patients. Mutations
were found more often in tissue from adenocarcinomas (12/21) than in tissue from tumors other than
nonadenocarcinomas ofthe lung (3/28). Among the adenocarcinoma patients, asbestos exposure was predic-
tive ofK-ras mutation (odds ratio, 4.9; 95% confidence interval, 0.7-34.3); in patients with other types oflung
cancer, the relation appeared to be an inverse one, but the numbers were small. The proportion of heavy
smokers (over50pack-years) was 60% amongpeople with K-ras mutations and35% amongthe K-ras-negative
subjects,suggestingthatsmokingcauses K-ras mutations. Ifmutations in K-ras genes are caused by smoking,
asbestos would act as a promoting agent by conferring selective growth conditions for clonal expansion on
these mutated cells. Asbestos may favor recruitment of (initiated) K-ras mutation-positive cells in the
multistage process ofcarcinogenesis by stimulating cellular growth.
Introduction
Lung cancer is the commonest fatal neoplastic disease
in the world. Most human lung cancers can be classified
into one of four major types: small cell carcinoma,
squamous cell carcinoma, adenocarcinoma, and large cell
carcinoma. Tobacco smoking causes all types of lung
cancer, but the risk for squamous cell and small cell
carcinomas ofthe lung is increased by cigarette smoking
to agreaterextentthantheriskforadenocarcinoma ofthe
lung (1).
An increased risk for lung cancer has been demon-
strated in studies of populations with occupational expo-
sure to asbestos fibers (2). Peripheral tumors (adeno-
carcinomas) appear to be more closely associated with
exposure to asbestos than other histological types oflung
cancer (3). The increase in risk for lung cancer occurs in
both smokers and nonsmokers, but because there is an
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important interaction between exposure to asbestos and
smoking, veryfew cases oflung cancer occurin nonsmok-
ing asbestos-exposed workers (4).
Carcinogenesis is amultistage process inwhich normal
growth, differentiation and development have gone awry.
Although it is clear that no single gene can account for all
the changes in the multistage progression from normalcy
to malignancy, certain oncogenes have emerged as being
particularly important. The prototypical example of such
oncogenes is ras (5), and it is generally conceded that ras
represents a nexus for the control ofcellular proliferation
(6,7). K-ras mutations are very rare among nonsmokers,
and it has therefore been assumed that carcinogens in
tobacco smoke cause the mutations directly (6-8).
The mode of carcinogenic action of asbestos is not
known; anumberofpotentialmechanisms atthemolecular
and cellular levels have, however, been proposed (9).
Increased serum levels of ras oncogene-related protein
(P21) were found in 7 of 18 patients with advanced
asbestosis who developed cancer (5 cases oflung cancer, 2
of pleural mesotheliomas) and in only 2 of 28 patients
without cancer (10). Also, people with asbestosis had ele-
vated serumlevels ofgrowthfactors,indicatingthatheavy
exposure to asbestos can stimulate cell growth.
Adenocarcinoma is the histological type oflung cancer
thatis clearlyassociated with exposure to asbestos, and itVAINIO ETAL.
Table 1. Characteristics oflung cancer patients by histological subtype.
Histological subtype No. ofcases Sex (M/F) Age, AM (SD) Pack-years, AM (SD)
Squamous cell carcinomab 22 20/2 63 (8.8) 42 (22)
Adenocarcinomab 21 18/3 60 (10) 42 (29)
Small cell carcinoma 4 3/1 63 (1.8) 30 (24)
Large cell carcinoma 2 2/0 72 (1.4) 62 (38)
All types combined 49 44/6 62 (9.1) 42 (26)
AM, arithmetic mean.
bNo data on smoking were available for one patient.
Tble 2. Odds ratio for adenocarcinoma associated with high expo-
sure to asbestos and point mutations in codons 12 or 13 ofK-ras.a
No. ofexposed
cases of Odds
Predictor adenocarcinomas ratio 95% CIb
Asbestos fibers
>3 x 106/g dried lung 9 3.45 0.94-12.6
K-ras positivity 12 11.1 2.54-45.3
aLogit model.
b95% Confidence interval.
is the type in which smoking plays a lesser role, in com-
parison to squamous cell cancer.Therefore, theinteraction
between exposure to asbestos and smoking might be
particularly strong in inducing adenocarcinoma. We con-
sidered, therefore, that this histological type would be a
good model for studying the potential mechanisms of
interaction.
In the present study, we examined the role ofmutations
in one oncogene, the K-ras gene, in the causation oflung
cancer and its potential role in the synergistic interaction
between asbestos and smoking at the molecular level,
especially in cases oflung adenocarcinoma.
Materials and Methods
Lung carcinoma specimens were obtained during tho-
racotomy at the Helsinki University Hospital. Of 49
patients, 21 had adenocarcinomas and the remainder had
mainly squamous-cell carcinomas (Table 1). DNA was iso-
lated from lung tumor samples by standard procedures.
Polymerase chain reaction amplification ofthe sequences
studied in the oligohybridization assay was performed as
described by Husgafvel-Pursiainen et al. (11). Asbestos
fibers were determinedinthelungtissuesbytransmission
electron microscopy, as described elsewhere (12). The data
were analyzed statistically by logistic regression (case-
referent type) and tabular analysis (cohort type).
Results
Point mutational activation of the K-ras oncogene was
studied in a set of DNA samples extracted from 49 lung
tumors. The distribution of tumor histology, with other
characteristics ofthe patients, is presented in Table 1.
Nine (43%) ofthe 21 adenocarcinoma cases and 5 (17%)
of the 28 nonadenomatous lung cancer cases had an
asbestos fiber concentration in the lungs that exceeded 3
x 106 fibers/g of dried lung, indicating occupational
asbestos exposure (12). This category of heavy asbestos
exposure was associated with an odds ratio for adenocar-
cinomaof3.5[95%confidenceinterval (CI),0.9-12.6;Table
2). Twelve (57%) ofthe adenocarcinoma cases and 3 (11%)
ofthe nonadenomatous lung cancers were K-ras-positive,
theoddsratioforadenocarcinomainK-ras-positivesbeing
significantly elevated (11.1; 95% CI, 2.54-45.3; Table 2).
Among the adenocarcinoma cases, asbestos exposure
was predictive ofK-ras mutation, though not significantly
so(oddsratio,4.9; 95%CI, 0.7-34.3; Table2). Incancersof
othercelltypes,therelationappearedtobeinverse,butthe
numbers were small (Table 3).
Another interpretation of the interrelations between
asbestos exposure, K-ras mutation, and histological type
of cancer is presented in Table 4. The risk for adenocar-
cinomarelative toothercelltypesisexpressed asthe odds
ratio for adenocarcinoma associated with different com-
binations of asbestos exposure and point mutations in
codons 12 or 13 of K-ras, with tho no mutation-low
asbestos exposure combination as the reference category
for the remaining three combinations. The highest odds
ratio(41.0; 95%CI,2.1-809)wasobservedforpatientswith
heavy asbestos exposure and K-ras mutation. The odds
ratioforthosewithlowerfibercontentandK-rasmutation
was also elevated but to a considerably lesser degree, not
quitereachingstatistical significance (oddsratio,4.8; 95%
CI, 0.9-25.3). The odds ratio for patients with high
asbestos exposure but no K-ras mutation was near unity.
The proportion ofall smokerswhowere heavy smokers
(over 50 pack-years ofcigarettes) was 60% amongpeople
with K-ras mutations and 35% among K-ras-negative
subjects. The corresponding odds ratio was 2.8 (nonsig-
nificant; Table 5).
Discussion
The interaction betweentobacco smoking and exposure
to asbestos in the causation of lung cancer is a highly
debatedissue [seereviewsbySteenland andThun(13)and
Saracci(4)]. Theinteractionpatternis somewhatvariable;
although the results of epidemiological studies could be
reconciledwith amultiplicative model, thisvariationinthe
strength of the interaction may reflect real differences
based on the fact that asbestos and smokingprobably act
at different stages of the carcinogenic process. Tobacco
smoking can obviously act at an early stage: tobacco
smoke contains a number ofDNA-damaging agents such
as polynuclear aromatic hydrocarbons (1). Because it has
been shown that asbestos and smoking have a multiplica-
tive effect in causing lung cancer, it maybe that relatively
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Table 3. Distribution of(number ofsubjects) and odds ratios for point mutations in codons 12 or 13 ofK-ras in adenocarcinoma patients,
according to asbestos fiber content in the lung tissue.
K-ras mutation"
Asbestos fiber content, Positive Negative Odds ratioa 95% CIa,b
per g dried lung M+F M M+F M (M+F) (M+F)
Adenocarcinoma
23 x 106 7 7 2 2 4.90 0.70-34.3
<3x106 5 4 7 5
All 12 11 9 7
Non-adenocarcinoma
23 x 106 0 0 5 5 NC NC
<3 x 106 3 2 20 18
All 3 2 25 23
All lung cancer
.3 x 106 7 7 7 7 3.38 0.91-12.5
<3x106 8 6 27 23
All 15 13 34 30
Abbreviations: M, male; F, female; NC, not calculable.
aLogit model.
b95% Confidence interval.
Table 4. Numbers ofcases of adenocarcinomas and
nonadenomatous lung cancer, and odds ratios for adenocarcinoma,
according to asbestos exposure and presence ofpoint mutations in
codons 12 or 13 ofK-ras in tumor tissue.'
Asbestos fibers/g dried lung
K-ras mutation > 3 x 106 <3 x 106
Positive
Number of adenocarcinomas 7 5
Number ofnonadenocarcinomas 0 3
Odds ratio 41.0 4.76
95% Confidence interval 2.1-809 0.90-25.3
Negative
Number ofadenocarcinomas 2 7
Number ofnonadenocarcinomas 5 20
Odds ratio 1.14 1.0
95% Confidence interval 0.18-7.28
aReferencecategory:asbestosfibers < 3 x 106/gdryweightand K-ras
negativity; logit model.
Table 5. Distribution (number ofsubjects) and odds ratios
for point mutations in codons 12 or 13 ofK-ras in
different categories ofcigarette smoking.a
K-ras mutation
Positive Negative
Category (n = 14) (n = 33)
Smokers
2 50 pack-years 6 8
< 50 pack-years 4 15
Ex-smokers 3 8
Never-smokers 1 2
Oddsratiofor 2 50pack-yearsb 2.81
95% Confidence interval 0.61-13.0
aLogit model. bReferejice category: < 50 pack-years (ex-and never-smokers
excluded).
small amounts of asbestos play an important role in car-
cinogenesis in people who smoke. These inferences would
be even stronger if we had a better mechanistic under-
standing ofthepossible modes ofaction ofthetwo agents.
Inthepresentstudy,inwhichlungcancersampleswere
obtained at surgery, we investigated the prevalence of
point mutations in the K-ras oncogene in tumor tissue
from the patients. K-ras mutations appeared to be
especially prevalent in adenocarcinomas, in accordance
with earlier findings (6,8,14). All of the adenocarcinoma
patients were either current or ex-smokers. The preva-
lenceofK-rasmutationswascommoneramongpeoplewho
smoked more (Table 5), supporting the view that tobacco
smoke is an important factor in the induction of point
mutations in K-ras in human lung adenocarcinomas.
Mutations in the codon 12 ofK-ras were mostly guanine-
to-thymine transversions-base changes that can be
caused, for example, by polynuclear aromatic hydrocar-
bons (11). For instance, in one study, benzo[a]pyrene-
induced mouse lung tumors harbored a K-ras mutation in
codon 12 in 80% ofanimals (15).
Asbestosisnotanagentthatcausespointmutations,but
it appears that exposure to asbestos increases the likeli-
hood of K-ras mutations in adenocarcinomas. There may
be several explanations for the increased prevalence of
mutations in K-ras in patients with adenocarcinomas who
had heavy exposure to asbestos. Asbestos fibers could
increase cell proliferation and, therefore, the recruitment
of mutated cells into the multistage process of carcino-
genesis. This effectwould be in linewith the multiplicative
effect observed in some epidemiological studies, suggest-
ingthattheeffects ofasbestosandsmokingwouldoccurat
different stages. Asbestos may act by increasing gene
expression and giving a selective growth advantage to
mutated cells. It has been shown that people heavily
exposed to asbestos have elevated levels ofgrowth factors
in their serum (10).
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